Literature DB >> 14149946

INITIAL EXPERIENCE WITH THROMBOTEST.

A L MILLER, G FARRER-BROWN, J PETHER.   

Abstract

The initial experience of using Thrombotest instead of Quick's one-stage prothrombin time to control anticoagulant therapy is described.Patients well controlled by the Quick test are often found to be over-anticoagulated by Thrombotest standards, so the introduction of Thrombotest has led to widespread reductions in dosage. No improvement in stability of control has been noted. The main advantages of Thrombotest seem to be its technical simplicity and the comparability of results obtained in different laboratories.

Entities:  

Keywords:  ANTICOAGULANTS; BLOOD COAGULATION TESTS; PHENINDIONE

Mesh:

Substances:

Year:  1964        PMID: 14149946      PMCID: PMC480713          DOI: 10.1136/jcp.17.2.182

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  5 in total

1.  Control of anticoagulant therapy. A comparison of the thrombotest, the prothrombin-proconvertin method, and the prothrombin time.

Authors:  C FICHERA
Journal:  Acta Med Scand       Date:  1962-09

2.  Thrombotest versus one-stage prothrombin-time determination.

Authors:  C B MOORE; M F BEELER
Journal:  N Engl J Med       Date:  1961-04-06       Impact factor: 91.245

3.  Thrombotest. A new method for controlling anticoagulant therapy.

Authors:  P A OWREN
Journal:  Lancet       Date:  1959-11-07       Impact factor: 79.321

4.  Relation between levels of plasma thromboplastin component (PTC) and prothrombin times by the P&P and Quick methods in patients receiving warfarin.

Authors:  S I RAPAPORT; S B AMES
Journal:  N Engl J Med       Date:  1962-07-19       Impact factor: 91.245

5.  Comparison of the thrombotest with the one-stage prothrombin time.

Authors:  A J QUICK; C V HUSSEY
Journal:  N Engl J Med       Date:  1961-12-28       Impact factor: 91.245

  5 in total
  1 in total

1.  Potentiation of anticoagulant therapy by oxyphenylbutazone. (A probable case).

Authors:  C B Hobbs; A L Miller; J H Thornley
Journal:  Postgrad Med J       Date:  1965-09       Impact factor: 2.401

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.